Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

News & Events

2014 News
 

2/3/2014
Celator Pharmaceuticals Announces New Date and Time for Presentation at 16th Annual BIO CEO and Investor Conference

1/9/2014
Celator Pharmaceuticals Reaches 50% Enrollment for CPX-351 Phase 3 Study

1/7/2014
Celator Pharmaceuticals Approved for Approximately $1.5 Million From New Jersey's Technology Business Tax Certificate Transfer Program

 

 

News Links:
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Upcoming Events

 

 

 



 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.